Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations
What Are the Projections for Pharmaceutical Excipients Market Size and CAGR During 2025-2029?
The pharmaceutical excipients market size has grown strongly in recent years. It will grow from $10257.72 billion in 2024 to $10822.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to strong economic growth in emerging markets, a surge in the sale of generic drugs and rising advanced healthcare infrastructure.
The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $13948.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to government initiatives, an increasing development of novel drugs, rising healthcare expenditure and a rapid growth in the elderly population will drive market growth. Major trends in the forecast period include focusing on sustainable packaging to reduce the use of plastics, focusing on mergers and acquisitions to strengthen market position, focusing on reducing greenhouse gas emissions and leveraging artificial intelligence to track nutrients, water levels and improve transparency in supply chains.
Claim your free report sample now:
What Are the Key Market Drivers and Opportunities in the Pharmaceutical Excipients Market?
The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market. Generic drugs are alternatives to the marketed brand-name drug in the same dosage form, safety, strength, route of administration, and quality. According to the India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines, the country’s generic drugs account for 20% of the global generic drug exports. Indian pharmaceutical companies received 300 generic drug approvals in the USA. The surge in the demand for generic drugs drives the pharmaceutical excipients market.
What Are the Key Segments in the Pharmaceutical Excipients Market?
The pharmaceutical excipients market covered in this report is segmented –
1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products
2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities
3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations
Subsegments:
1) By Inorganic Chemicals: Salts, Oxides, Silicates
2) By Organic Chemicals: Sugars, Polymers, Oils And Fats
3) By Other Products: Natural Excipients, Coatings, Antioxidants
What Are the Emerging Market Trends That Companies Should Monitor in Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipient market are introducing advanced excipients, such as high-purity excipients, to enhance drug formulation stability, improve bioavailability, and support complex drug delivery systems. High-purity excipients refer to pharmaceutical excipients that have undergone advanced purification processes to remove impurities and contaminants. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, launched three new VitiPure excipients designed to enhance the stability and solubility of active pharmaceutical ingredients (APIs). These include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer with low bioburden. Targeting various drug delivery applications, especially for sensitive formulations like mRNA vaccines and biologics, these excipients meet the growing demand for high-purity ingredients while adhering to stringent regulatory standards.
Who Are the Top Competitors in the Pharmaceutical Excipients Market?
Major companies operating in the pharmaceutical excipients market include BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances, Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours, Inc., Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Actelion Pharmaceuticals UK Ltd, Colorcon, MEGGLE GmbH & Co. KG, Boehringer Ingelheim International GmbH, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, Pfizer, AbbVie Inc, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma
Get the full pharmaceutical excipients market report here:
Which Regions Offer the Highest Potential for Pharmaceutical Excipients Market Expansion?
North America is the largest region in the pharmaceutical excipients market in 2024. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in the pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment